Macrolide susceptibility and β-lactamase production among Haemophilus influenzae isolates in the United States, 1996-1997

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3313-3314

  Hogan, Patricia A ^a   Sheehan, Daniel J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BETA LACTAMASE; CLARITHROMYCIN; ERYTHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CLINICAL TRIAL; DRUG ACTIVITY; ENZYME RELEASE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL;

EID: 0031758703     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3313     Document Type: Article

References (6)

1. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2419-2425.
2. Doern, G. V., A. B. Brueggemann, G. Pierce, H. P. Holley, Jr., and A. Rauch. 1997. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41:292-297.
3. Farmer, S., Z. Li, and R. E. W. Hancock. 1992. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. J. Antimicrob. Chemother. 29:27-33.
4. Fung-Tomc, J. C., E. Huczko, T. Stickle, B. Minassian, B. Kolek, K. Denbleyker, D. Bonner, and R. Kessler. 1995. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrob. Agents Chemother. 39:533-538.
5. National Committee for Clinical Laboratory Standards. 1995. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
6. National Committee for Clinical Laboratory Standards. 1997. Zone diameter interpretive standards and equivalent minimum inhibitory concentration (MIC) breakpoints for Haemophilus spp. Approved standard M100-S7. National Committee for Clinical Laboratory Standards, Villanova, Pa.